Viking Therapeutics Inc.: Miss — EPS -$1.55, Revenue $0

VKTXViking Therapeutics Inc.•Q3 2026•Oct 28, 2026, 4:05 PM EDT

0

Earnings MissQ3 2026 · After-market

Did Viking Therapeutics Inc. (VKTX) beat earnings today?

@trystockwhiz

No, Viking Therapeutics Inc. (VKTX) missed Wall Street analyst expectations for Q3 2026, reporting lower-than-expected EPS.

Earnings Per Share-47.62% surprise

-$1.55Actual

Expected: -$1.05

vs. year ago -91.4%

Total RevenueIn line

$0MActual

Expected: $0M

Released Oct 28 · 4:05 PM ET